Search Medical Condition
Please enter condition
Please choose location from dropdown

Psychosis Clinical Trials

A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1028) clinical trials

The name of this trial is MissionAD2. This 24-month treatment, multicenter, double-blind, placebo-controlled, parallel group, Phase 3 study in participants with Early Alzheimer's Disease (EAD) including mild cognitive impairment (MCI) due to AD/Prodromal AD and the early stages of mild AD will be conducted to evaluate the efficacy and safety ...

Phase N/A

The purpose of this study is to determine the effects of CNP520 on cognition, global clinical status, and underlying AD pathology, as well as the safety of CNP520, in people at risk for the onset of clinical symptoms of AD based on their age, APOE genotype and elevated amyloid.

Phase N/A

The study will evaluate the efficacy and safety of ITI-007 in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Phase N/A

The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with early AD. Secondary objectives are to assess the ...

Phase N/A

The purpose of this research study is to learn about normal brain function and brain function in various stages of Alzheimer’s disease. There will be 1 baseline visit that will take approximately 7 hours and 1 optional follow up visit (2.5 to 3 years later). Study procedures include PET scans, ...

Phase N/A

Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for major depressive disorder in teenagers. Qualified participants receive study-related medical care from a board-certified physician, exams and evaluations.

Phase N/A

The objective of this study is to assess the safety and tolerability of the study drug given orally twice daily for 28 days. The study will also assess the effects of study drug on oral and cerebrospinal fluid biomarkers. The study evaluations include 2 detailed dental examinations and 2 lumbar ...

Phase

If you or someone you love suffers from Mild Cognitive Impairment due to Alzheimer's Disease, or mild Alzheimer's Disease, you may be eligible to participate in a research study.

Phase

ActivMed Practices and Research is looking for volunteers to participate in a device research study on Alzheimer's Disease and memory loss.

Phase N/A